Lefamulin, a recently approved novel antibacterial agent to fight against community-acquired bacterial pneumonia

Lefamulin, a recently approved novel antibacterial agent to fight against community-acquired bacterial pneumonia

Bibliographic Details
Main Authors: Shouvik Choudhury, Moumita Bala, Dwaipayan Sarathi Chakraborty, Sandeep Lahiry
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2021-01-01
Series:Lung India
Online Access:http://www.lungindia.com/article.asp?issn=0970-2113;year=2021;volume=38;issue=3;spage=300;epage=301;aulast=Choudhury
id doaj-76b1fdf804c44e749bb7c4b5f385458c
record_format Article
spelling doaj-76b1fdf804c44e749bb7c4b5f385458c2021-05-05T11:30:36ZengWolters Kluwer Medknow PublicationsLung India0970-21130974-598X2021-01-0138330030110.4103/lungindia.lungindia_93_20Lefamulin, a recently approved novel antibacterial agent to fight against community-acquired bacterial pneumoniaShouvik ChoudhuryMoumita BalaDwaipayan Sarathi ChakrabortySandeep Lahiryhttp://www.lungindia.com/article.asp?issn=0970-2113;year=2021;volume=38;issue=3;spage=300;epage=301;aulast=Choudhury
collection DOAJ
language English
format Article
sources DOAJ
author Shouvik Choudhury
Moumita Bala
Dwaipayan Sarathi Chakraborty
Sandeep Lahiry
spellingShingle Shouvik Choudhury
Moumita Bala
Dwaipayan Sarathi Chakraborty
Sandeep Lahiry
Lefamulin, a recently approved novel antibacterial agent to fight against community-acquired bacterial pneumonia
Lung India
author_facet Shouvik Choudhury
Moumita Bala
Dwaipayan Sarathi Chakraborty
Sandeep Lahiry
author_sort Shouvik Choudhury
title Lefamulin, a recently approved novel antibacterial agent to fight against community-acquired bacterial pneumonia
title_short Lefamulin, a recently approved novel antibacterial agent to fight against community-acquired bacterial pneumonia
title_full Lefamulin, a recently approved novel antibacterial agent to fight against community-acquired bacterial pneumonia
title_fullStr Lefamulin, a recently approved novel antibacterial agent to fight against community-acquired bacterial pneumonia
title_full_unstemmed Lefamulin, a recently approved novel antibacterial agent to fight against community-acquired bacterial pneumonia
title_sort lefamulin, a recently approved novel antibacterial agent to fight against community-acquired bacterial pneumonia
publisher Wolters Kluwer Medknow Publications
series Lung India
issn 0970-2113
0974-598X
publishDate 2021-01-01
url http://www.lungindia.com/article.asp?issn=0970-2113;year=2021;volume=38;issue=3;spage=300;epage=301;aulast=Choudhury
work_keys_str_mv AT shouvikchoudhury lefamulinarecentlyapprovednovelantibacterialagenttofightagainstcommunityacquiredbacterialpneumonia
AT moumitabala lefamulinarecentlyapprovednovelantibacterialagenttofightagainstcommunityacquiredbacterialpneumonia
AT dwaipayansarathichakraborty lefamulinarecentlyapprovednovelantibacterialagenttofightagainstcommunityacquiredbacterialpneumonia
AT sandeeplahiry lefamulinarecentlyapprovednovelantibacterialagenttofightagainstcommunityacquiredbacterialpneumonia
_version_ 1721464582500777984

Similar Items